Vilnius, Lithuania, and Waltham, MA, US – December 9, 2020 – Northway Biotechpharma, providing end-to-end contract drug development and manufacturing (CDMO) services, announces brand name change to Northway Biotech. Along…
The annual growth of the Lithuanian life sciences sector is 19%, which is one of the most rapid growth paces across the European Union. Lithuania’s potential is defined by well-developed infrastructure, universities and research centers, growing industry, significant foreign investments and national strategic directions.
Lithuania has been gradually becoming one of the high tech centers in the region. 90% of Lithuanian biotechnological, pharmaceutical products and medical devices are exported globally. LBTA represent as Lithuanian Health Technology Ecosystem within ECH Alliance global network.
Bioeconomy is a part of economy that produce renewable raw materials (biomass) and processes these raw materials and biowaste into value-added products – food, feed, industrial products, bioenergy. LBTA participates in national bioeconomy strategy development and implementation.
Virtual event | Virtual event